MRC1 and neoplasm: We believed a reduction in the number of deaths and reduced rate of tumor growth in ALKi and anti-PD-1 combination treatment group partially result from reduction of CD206+ TAM infiltration and increased cytotoxic T-cell recruitment (Fig. 5).